CONCORD DRUGS
Back to Income Statement
|
CONCORD DRUGS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Sales | ₹45 Cr | ₹45 Cr | ₹52 Cr | ₹59 Cr |
What is the latest Revenue of CONCORD DRUGS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹59 Cr |
How is Revenue of CONCORD DRUGS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | 0.71 | |
| Mar2024 | ₹45 Cr | -13.74 | |
| Mar2023 | ₹52 Cr | -11.66 | |
| Mar2022 | ₹59 Cr | - | |
Compare Revenue of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹106.8 Cr | 0.1% | 9.3% | 22.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 0.1% |
9.3% |
22.1% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses